
Professor Hannah Batchelor
Strathclyde Institute of Pharmacy and Biomedical Sciences
Back to staff profile
Back to staff profile
Quantification of drug metabolising enzymes and transporter proteins in the paediatric duodenum via LC-MS/MS proteomics using a QconCAT technique Goelen Jan, Farrell Gillian, McGeehan Jonathan, Titman Christopher M, Rattray Nicholas JW, Johnson Trevor N, Horniblow Richard D, Batchelor Hannah K European Journal of Pharmaceutics and Biopharmaceutics Vol 191, pp. 68-77 (2023) https://doi.org/10.1016/j.ejpb.2023.08.011 Colour of medicines and children's acceptability? A systematic literature review of children's perceptions about colours of oral dosage forms Alessandrini Elisa, Gonakova Milena, Batchelor Hannah, Gizurarson Sveinbjorn, Iurian Sonia, Klein Sandra, Schaufelberger Daniel, Turner Roy, Walsh Jennifer, Tuleu Catherine Pharmaceutics Vol 15 (2023) https://doi.org/10.3390/pharmaceutics15071992 Optimizing expert and patient input in pediatric trial design : lessons learned and recommendations from a collaboration between conect4children and European Patient‐CEntric ClinicAl TRial PLatforms Dhaenens Britt A E, Mahler Fenna, Batchelor Hannah, Dicks Pamela, Gaillard Segolene, Nafria Begonya, Kopp‐Schneider Annette, Ribeiro Maria Alexandra, Schwab Matthias, Sparber‐Sauer Monika, Leubner Jonas, de Wildt Saskia N, Oostenbrink Rianne Clinical and Translational Science Vol 16, pp. 1458-1468 (2023) https://doi.org/10.1111/cts.13547 Integration of biorelevant pediatric dissolution methodology into PBPK modeling to predict in vivo performance and bioequivalence of generic drugs in pediatric populations : a carbamazepine case study Pawar Gopal, Wu Fang, Zhao Liang, Fang Lanyan, Burckart Gilbert J, Feng Kairui, Mousa Youssef M, Al Shoyaib Abdullah, Jones Marie-Christine, Batchelor Hannah K AAPS Journal Vol 25 (2023) https://doi.org/10.1208/s12248-023-00826-1 Use of in vitro Dynamic Colon Model (DCM) to inform a physiologically based biopharmaceutic model (PBBM) to predict the in vivo performance of a modified-release formulation of theophylline Stamatopoulos Konstantinos, O’Farrell Connor, Simmons Mark J H, Batchelor Hannah K, Mistry Nena Pharmaceutics Vol 15 (2023) https://doi.org/10.3390/pharmaceutics15030882 The pipeline for drugs for control and elimination of neglected tropical diseases : 1. Anti-infective drugs for regulatory registration Pfarr Kenneth M, Krome Anna K, Al-Obaidi Issraa, Batchelor Hannah, Vaillant Michel, Hoerauf Achim, Opoku Nicholas O, Kuesel Annette C Parasites and Vectors Vol 16 (2023) https://doi.org/10.1186/s13071-022-05581-4
Publications
Back to staff profile
Using paediatric GI data to better understand dissolution and absorption in paediatric population Speaker 3/3/2023 Integration of biorelevant dissolution with oral PBPK to support BE evaluation for pediatric drugs Speaker 2/3/2023 Generation and integration of paediatric gastrointestinal physiological data into PBPK software Speaker 17/11/2022 Oral PBPK to support bioequivalence evaluation for pediatric drugs Speaker 27/10/2022 MiniMox -Treatment for all: Developing a paediatric formulation moxidectin for neglected infectious diseases Speaker 21/9/2022 APS PharmSci 2022 Participant 7/9/2022
GiBio Gastrointestinal bioreactor to evaluate ingestible medicines and inform formulation and manufacture (EPSRC Strategic equipment) Batchelor, Hannah (Principal Investigator) Florence, Alastair (Co-investigator) Horan, Linda (Co-investigator) Khadra, Ibrahim (Co-investigator) McArthur, Stephen (Co-investigator) 01-Jan-2022 - 30-Jan-2025 DTP 2224 University of Strathclyde | Abu-Rajab Tamimi, Rana Khadra, Ibrahim (Principal Investigator) Batchelor, Hannah (Co-investigator) Abu-Rajab Tamimi, Rana (Research Co-investigator) 01-Jan-2022 - 01-Jan-2025 Mechanistic understanding of the drug-colloidal structure interplay and how this may affect absorption Batchelor, Hannah (Principal Investigator) 01-Jan-2022 - 30-Jan-2025 Industrial contribution for REA studentship: Development of simulated paediatric intestinal fluid to better predict drug absorption in children Batchelor, Hannah (Principal Investigator) 01-Jan-2021 - 30-Jan-2024 Treatment for all: developing a paediatric formulation of moxidectin for neglected infectious diseases (MiniMox) EDCTP Research and Innovation Action Batchelor, Hannah (Principal Investigator) 01-Jan-2021 - 30-Jan-2024
Professional Activities
Projects
Back to staff profile
Contact
Professor
Hannah
Batchelor
Strathclyde Institute of Pharmacy and Biomedical Sciences
Email: hannah.batchelor@strath.ac.uk
Tel: Unlisted